These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7048046)

  • 21. The role of complement in viral infections. III. Activation of the classical and alternative complement pathways by Sindbis virus.
    Hirsch RL; Winkelstein JA; Griffin DE
    J Immunol; 1980 May; 124(5):2507-10. PubMed ID: 7365263
    [No Abstract]   [Full Text] [Related]  

  • 22. [Complement: mechanisms of activation, functions, analysis].
    Dessaint JP; Wattre P; Santoro F; Capron A
    Lille Med; 1979; 24(7):551-8. PubMed ID: 397392
    [No Abstract]   [Full Text] [Related]  

  • 23. Regulation of complement activity by vaccinia virus complement-control protein.
    McKenzie R; Kotwal GJ; Moss B; Hammer CH; Frank MM
    J Infect Dis; 1992 Dec; 166(6):1245-50. PubMed ID: 1431243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody and complement in viral infections.
    Lachmann PJ
    Br Med Bull; 1985 Jan; 41(1):3-6. PubMed ID: 3882187
    [No Abstract]   [Full Text] [Related]  

  • 25. IgG on mouse erythrocytes augments activation of the human alternative complement pathway by enhancing deposition of C3b.
    Moore FD; Fearon DT; Austen KF
    J Immunol; 1981 May; 126(5):1805-9. PubMed ID: 6908606
    [No Abstract]   [Full Text] [Related]  

  • 26. Characterization of measles virus-specific cytotoxic antibodies by use of a chronically infected cell line.
    Ehrnst AC
    J Immunol; 1975 Mar; 114(3):1077-82. PubMed ID: 1089724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The interaction of cells persistently infected with canine distemper virus with antiviral antibody and complement.
    Gorman NT
    Cell Immunol; 1983 Apr; 77(2):242-8. PubMed ID: 6850842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response.
    Iankov ID; Pandey M; Harvey M; Griesmann GE; Federspiel MJ; Russell SJ
    J Virol; 2006 Sep; 80(17):8530-40. PubMed ID: 16912303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody and complement-binding activity of viable and nonviable human spermatozoa.
    Vogelpoel FR; te Velde ER; Scheenjes E; Van Kooy R; Kremer J; Verhoef J
    Arch Androl; 1987; 18(3):189-97. PubMed ID: 3118830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of injury of virus-infected cells by antiviral antibody and complement: participation of IgG, F(ab')2, and the alternative complement pathway.
    Perrin LH; Joseph BS; Cooper NR; Oldstone MB
    J Exp Med; 1976 May; 143(5):1027-41. PubMed ID: 177712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Function and genetic control of complement system (author's transl)].
    Tachibana T
    Ryumachi; 1978 Jul; 18(4):267-77. PubMed ID: 358416
    [No Abstract]   [Full Text] [Related]  

  • 32. Activation of complement by bovine respiratory syncytial virus-infected cells.
    Kimman TG; Daha MR; Brinkhof JM; Westenbrink F
    Vet Immunol Immunopathol; 1989 Jul; 21(3-4):311-25. PubMed ID: 2800328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of complement by antibodies to the keratosulphate-like host antigen of Sendai virus.
    Fadnes P; Haukenes G
    Acta Pathol Microbiol Scand C; 1980 Apr; 88(2):73-6. PubMed ID: 6247879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Alternative complement activation pathway. Its mechanism, importance and quantitative determination].
    Gancevici GG; Popescu C
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1984; 29(3):209-21. PubMed ID: 6390651
    [No Abstract]   [Full Text] [Related]  

  • 35. [Progress in the knowledge of complement. I. Structure, activation and control of the complement system].
    Lesavre P; Leibowitch J
    Nouv Presse Med; 1979 Jun; 8(29):2385-7. PubMed ID: 493022
    [No Abstract]   [Full Text] [Related]  

  • 36. Activation of complement pathways by univalent antibody derivatives with intact Fc zones.
    Watts HF; Anderson VA; Cole VM; Stevenson GT
    Mol Immunol; 1985 Jul; 22(7):803-10. PubMed ID: 3849671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of complement-dependent antibody-mediated lysis of target cells acutely infected with measles.
    Hicks JT; Klutch MJ; Albrecht P; Frank MM
    J Immunol; 1976 Jul; 117(1):208-15. PubMed ID: 819582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of measles virus expression by noncytolytic antibody in an immortalized macrophage cell line.
    Goldman MB; O'Bryan TA; Buckthal DJ; Tetor LM; Goldman JN
    J Virol; 1995 Feb; 69(2):734-40. PubMed ID: 7815537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoglobulin-independent utilization of the classical complement pathway in opsonophagocytosis of Escherichia coli by human peripheral leukocytes.
    Leist-Welsh P; Bjornson AB
    J Immunol; 1982 Jun; 128(6):2643-51. PubMed ID: 6210733
    [No Abstract]   [Full Text] [Related]  

  • 40. The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum.
    Gadd KJ; Reid KB
    Biochem J; 1981 May; 195(2):471-80. PubMed ID: 7316962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.